Skip to content
← Back to this collection

PUBLICATIONS · 22889759

Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2012 Sep 27
First author
Mateos MV

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Mateos MV
      type
      Author
    2. name
      Oriol A
      type
      Author
    3. name
      Martínez-López J
      type
      Author
    4. name
      Gutiérrez N
      type
      Author
    5. name
      Teruel AI
      type
      Author
    6. name
      López de la Guía A
      type
      Author
    7. name
      López J
      type
      Author
    8. name
      Bengoechea E
      type
      Author
    9. name
      Pérez M
      type
      Author
    10. name
      Polo M
      type
      Author
    11. name
      Palomera L
      type
      Author
    12. name
      de Arriba F
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Mateos MV
      type
      Author
    2. name
      Oriol A
      type
      Author
    3. name
      Martínez-López J
      type
      Author
    4. name
      Gutiérrez N
      type
      Author
    5. name
      Teruel AI
      type
      Author
    6. name
      López de la Guía A
      type
      Author
    7. name
      López J
      type
      Author
    8. name
      Bengoechea E
      type
      Author
    9. name
      Pérez M
      type
      Author
    10. name
      Polo M
      type
      Author
    11. name
      Palomera L
      type
      Author
    12. name
      de Arriba F
      type
      Author
    bibliography ids
    1. nci-bib-8bdb431ce5a5b27bb889ac2e
    book metadata
    content sha256
    73f1a002b1ad6375a8b4b9778deb7fee9d67561c64a7f07c0a1b3a11fd1ef3a5
    document type
    citation
    dois
    1. 10.1182/blood-2012-05-427815
    electronic publication date
    display
    2012 Aug 13
    precision
    day
    year
    2012
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:22889759
    immutable id
    pubmed:22889759@73f1a002b1ad6375a8b4b9778deb7fee9d67561c64a7f07c0a1b3a11fd1ef3a5
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    13
    name
    Blood
    nlm unique id
    7603509
    pages
    2581-8
    volume
    120
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      22889759
      provenance
      batch id
      1e3045de9f47a5ccd566
      provider
      NCBI PubMed ESummary
      record sha256
      f88fb76fd53334d92ed424be29ae2b0ec2a3fcdb0798c40af47a2dfd186f5bc0
      response sha256
      0c42e87ee821aef9d804e2d77dfdba8876f375111db163986dd22ba43a3d6a52
      retrieved at
      2026-09-09T23:46:50.128287+00:00
      publication date
      display
      2012 Sep 27
      precision
      day
      year
      2012
      publication types
      1. Journal Article
      2. Randomized Controlled Trial
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/22889759/
      title
      Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial.

      Preserved source evidence · Not medical advice